FDA WARNING_LETTER - Sampson, Clint - May 24, 2011

On August 10, 2011, the FDA issued a Warning Letter to Clint Sampson, owner of Clint Sampson Farm, following an investigation on May 23-24, 2011, of his beef cattle operation in Melrose, Wisconsin. The investigation revealed multiple violations of the Federal Food, Drug, and Cosmetic Act.

A beef cow sold for slaughter on December 29, 2010, was found to be adulterated. Tissue samples from the animal contained tilmicosin at 26.74 ppm and flunixin at 7.15 ppm in the liver, exceeding the established tolerances of 1.2 ppm and 0.125 ppm, respectively. This constitutes adulteration under section 402(a)(2)(C)(ii) of the Act.

The operation was also cited for insanitary conditions under section 402(a)(4), as inadequate record-keeping and lack of an inventory system for drugs made it likely that medicated animals with harmful residues could enter the food supply.

Furthermore, the new animal drugs tilmicosin and flunixin were found to be adulterated under section 501(a)(5) and unsafe under section 512(a) due to extralabel use not in compliance with 21 CFR Part 530. Specifically, these prescription drugs were used without a valid veterinarian/client